Risk Factors for Plaque Vulnerability in a Community Population: Endothelial Function and Arterial Stiffness Indexes

Yan Zhang1, Shiyu Lei2, Fangfang Liu3

  • 1Department of Evidence Based Medicine and Social Medicine, School of Public Health, Chengdu Medical College, Chengdu, Sichuan, China; Infectious Diseases and Immunization Planning Section, Banan District Center for Disease Control and Prevention, Chongqing, China.

PubMed

Insights

Male sex, increased aortic augmentation index (AIx), decreased systemic elastic vascular resistance (SEVR), and shorter carotid-femoral artery distance are linked to vulnerable plaques. These findings aid in early cardiovascular and cerebrovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Atherosclerotic plaque rupture is a leading cause of cardiovascular mortality.
  • Early identification of vulnerable plaques is crucial for preventing acute cardiovascular events.
  • Current preventive strategies for atherosclerotic vascular disease require improvement.

Purpose of the Study:

  • To identify key risk factors for carotid artery plaque stability and vulnerability.
  • To provide insights for early prevention of cardiovascular and cerebrovascular diseases.

Main Methods:

  • 136 patients with stable and 635 with vulnerable plaques were analyzed.
  • Arterial stiffness and endothelial function were assessed.
  • Logistic regression was used to analyze associations with plaque stability.

Main Results:

  • No significant differences in cf-PWV or RHI between stable and vulnerable plaque groups.
  • Male sex, smoking history, ejection, and duration were risk factors for plaque stability.
  • Male sex, increased Aortic AIx, decreased SEVR, and shorter carotid-femoral distance independently correlated with plaque vulnerability.

Conclusions:

  • RHI and cf-PWV showed no relation to plaque stability.
  • Male sex, decreased SEVR, increased Aortic AIx, and shorter carotid-femoral artery distance increase the risk of vulnerable plaques.
  • Findings offer a reference for early cardiovascular and cerebrovascular disease prevention.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
765
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
285
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
430
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291